М.Мөнхзол
Loading...
Товч нэр
М.Мөнхзол
Бүтэн нэр
Малчинхүү Мөнхзол
Латин нэр
Malchinkhuu Munkhzol
Эрдмийн цол
Профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
3 results
Now showing 1 - 3 of 3
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, GW26-e2958 To study involvement of serum matrix metalloproteinase-9 in pathogenesis of myocardial infarction(Elsevier BV, 2015-10-01); ; ;Zorigoo Shagdar - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Involvement of Serum Matrix Metalloproteinase-9 in the Pathogenesis of Acute Myocardial Infarction(Mongolian National University of Medical Sciences, 2016-11-25); ; ;Jung Rae Cho ;Namho LeeGandulam ChuluunkhuuObjectives: Prior studies indicate that matrix metalloproteinase-9 (MMP-9) plays a key role in pathogenesis of plaque rupture. The objective of this study was to evaluate the involvement of serum MMP-9 enzyme at pathogenesis of the plaque rupture in coronary atherosclerosis. Methods: The study enrolled 80 consecutive patients who underwent percutaneous coronary intervention in our institution. Inclusion in the case group (n = 40) required a ruptured coronary atherosclerotic plaque confirmed by conventional angiography, whereas inclusion in the control group (n = 40) required stable coronary atherosclerosis. Serum MMP-9 levels were determined by ELISA. Cardiac Infarction Injury Score (CIIS) by electrocardiogram and Gensini score (Coronary Angiographic Scoring System) were utilized for assessing the severity of coronary artery disease. Results: The average level of MMP-9 was significantly higher in the case group than in the control group (396±155 ng/mL vs. 223±87 ng/mL, p<0.001) with further demonstration that MMP-9 is an independent predictor of plaque rupture (β = 0.985, p><0.001). MMP-9 is well correlated with Gensini and CIIS score (r = 0.552, p ><0.01 and r = 0.340, p><0.01, respectively). Furthermore, serum MMP-9 enzyme significantly increased in accordance with the severity of the myocardium damage (p ><0.01) by CIIS score. Conclusion: MMP-9 plays a role at pathogenesis of plaque rupture in coronary atherosclerosis.><0.001) with further demonstration that MMP-9 is an independent predictor of plaque rupture (β = 0.985, p<0.001). MMP-9 is well correlated with Gensini and CIIS score (r = 0.552, p ><0.01 and r = 0.340, p><0.01, respectively). Furthermore, serum MMP-9 enzyme significantly increased in accordance with the severity of the myocardium damage (p ><0.01) by CIIS score. Conclusion: MMP-9 plays a role at pathogenesis of plaque rupture in coronary atherosclerosis.><0.001). MMP-9 is well correlated with Gensini and CIIS score (r = 0.552, p<0.01 and r=0.340, p<0.01, respectively). Furthermore, serum MMP-9 enzyme significantly increased in accordance with the severity of the myocardium damage (p<0.01) by CIIS score. Conclusion: MMP-9 plays a role at pathogenesis of plaque rupture in coronary atherosclerosis. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Elevated Levels of Anti-oxLDL Antibody in Relation with Acute Myocardial Infarction(Mongolian National University of Medical Sciences, 2021-07-01); ;Jung Rae ChoiObjectives: We aimed to determine the serum level of anti-oxLDL antibody at the involving of acute myocardial infarction. Methods: In the case-control study, patients with acute myocardial infarction (coronary stenosis > 85%) as determined by quantities coronary angiography in the case group (n = 26) and healthy people with carotid artery stenosis (< 0.7 mm) have been involved in the control group (n = 50). We determined Anti-oxLDL antibody and oxLDL titers by ELISA. Results: Anti-oxLDL antibody levels for the case group were greater than the control group (p < 0.01). Using binary logistic regression, the anti-oxLDL antibody was significantly associated with acute myocardial infarction (OR = 1.082, p < 0.01). Conclusions: Elevated serum anti-oxLDL antibodies may be a risk factor for developing acute myocardial infarction and concerning the correlation of anti-oxLDL antibodies and acute myocardial infarction
